arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

INSULET CORP

PODD
$136.49 ▼ -2.92 (-2.09%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
68 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
77
Health
Good
Bullish
auto_awesome

Analytical Summary

INSULET CORP shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $9.5B
Dividend Yield
Revenue Growth 23.5%
Op. Margin 16.2%
ROIC 7.3%
FCF / Share $0.81
Trailing P/E 99.6x
Price / Book 6.7x
FCF Yield 0.6%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$801.70M
↑ +23.5%
Net Income Profit after all expenses
$95.00M
↑ +322.2%
Operating Margin Operating profit as % of sales
16.2%
↑ +0.9% 71th
FCF / Share Free cash flow per share
$0.81
↓ -36.9%
Long-Term Debt Long-term obligations
$1.40B
— +0.1%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
68
Returns
82
Financial Health
82
Cash Quality
80

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters